628 related articles for article (PubMed ID: 13680365)
1. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype.
King RA; Pietsch J; Fryer JP; Savage S; Brott MJ; Russell-Eggitt I; Summers CG; Oetting WS
Hum Genet; 2003 Nov; 113(6):502-13. PubMed ID: 13680365
[TBL] [Abstract][Full Text] [Related]
2. Electron microscopic DOPA reaction test for oculocutaneous albinism.
Takizawa Y; Kato S; Matsunaga J; Aozaki R; Tomita Y; Nishikawa T; Shimizu H
Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771
[TBL] [Abstract][Full Text] [Related]
3. Mutational Analysis of the TYR and OCA2 Genes in Four Chinese Families with Oculocutaneous Albinism.
Wang Y; Wang Z; Chen M; Fan N; Yang J; Liu L; Wang Y; Liu X
PLoS One; 2015; 10(4):e0125651. PubMed ID: 25919014
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the human tyrosinase gene associated with tyrosinase related oculocutaneous albinism (OCA1). Mutations in brief no. 204. Online.
Oetting WS; Fryer JP; King RA
Hum Mutat; 1998; 12(6):433-4. PubMed ID: 10671066
[TBL] [Abstract][Full Text] [Related]
5. Tyrosinase gene analysis in Japanese patients with oculocutaneous albinism.
Goto M; Sato-Matsumura KC; Sawamura D; Yokota K; Nakamura H; Shimizu H
J Dermatol Sci; 2004 Sep; 35(3):215-20. PubMed ID: 15381243
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
Nakamura E; Miyamura Y; Matsunaga J; Kano Y; Dakeishi-Hara M; Tanita M; Kono M; Tomita Y
J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
[TBL] [Abstract][Full Text] [Related]
7. Genetic analyses of oculocutaneous albinism types 1 and 2 with four novel mutations.
Yang Q; Yi S; Li M; Xie B; Luo J; Wang J; Rong X; Zhang Q; Qin Z; Hang L; Feng S; Fan X
BMC Med Genet; 2019 Jun; 20(1):106. PubMed ID: 31196117
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
Oetting WS; King RA
Hum Mutat; 1993; 2(1):1-6. PubMed ID: 8477259
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive study of oculocutaneous albinism type 1 reveals three previously unidentified alleles on the TYR gene.
Lin YY; Wei AH; He X; Zhou ZY; Lian S; Zhu W
Eur J Dermatol; 2014; 24(2):168-73. PubMed ID: 24721949
[TBL] [Abstract][Full Text] [Related]
10. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase.
Toyofuku K; Valencia JC; Kushimoto T; Costin GE; Virador VM; Vieira WD; Ferrans VJ; Hearing VJ
Pigment Cell Res; 2002 Jun; 15(3):217-24. PubMed ID: 12028586
[TBL] [Abstract][Full Text] [Related]
11. Two novel tyrosinase (TYR) gene mutations with pathogenic impact on oculocutaneous albinism type 1 (OCA1).
Ghodsinejad Kalahroudi V; Kamalidehghan B; Arasteh Kani A; Aryani O; Tondar M; Ahmadipour F; Chung LY; Houshmand M
PLoS One; 2014; 9(9):e106656. PubMed ID: 25216246
[TBL] [Abstract][Full Text] [Related]
12. Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.
Dolinska MB; Kus NJ; Farney SK; Wingfield PT; Brooks BP; Sergeev YV
Pigment Cell Melanoma Res; 2017 Jan; 30(1):41-52. PubMed ID: 27775880
[TBL] [Abstract][Full Text] [Related]
13. Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico.
Santiago Borrero PJ; Rodríguez-Pérez Y; Renta JY; Izquierdo NJ; Del Fierro L; Muñoz D; Molina NL; Ramírez S; Pagán-Mercado G; Ortíz I; Rivera-Caragol E; Spritz RA; Cadilla CL
J Invest Dermatol; 2006 Jan; 126(1):85-90. PubMed ID: 16417222
[TBL] [Abstract][Full Text] [Related]
14. Mutation spectrum of the TYR and SLC45A2 genes in patients with oculocutaneous albinism.
Ko JM; Yang JA; Jeong SY; Kim HJ
Mol Med Rep; 2012 Apr; 5(4):943-8. PubMed ID: 22294196
[TBL] [Abstract][Full Text] [Related]
15. Polymorphic sequences of the tyrosinase gene: allele analysis on 16 OCA1 patients in Japan indicate that three polymorphic sequences in the tyrosinase gene promoter could be powerful markers for indirect gene diagnosis.
Tanita M; Matsunaga J; Miyamura Y; Dakeishi M; Nakamura E; Kono M; Shimizu H; Tagami H; Tomita Y
J Hum Genet; 2002; 47(1):1-6. PubMed ID: 11829136
[TBL] [Abstract][Full Text] [Related]
16. Identification of a functionally significant tri-allelic genotype in the Tyrosinase gene (TYR) causing hypomorphic oculocutaneous albinism (OCA1B).
Norman CS; O'Gorman L; Gibson J; Pengelly RJ; Baralle D; Ratnayaka JA; Griffiths H; Rose-Zerilli M; Ranger M; Bunyan D; Lee H; Page R; Newall T; Shawkat F; Mattocks C; Ward D; Ennis S; Self JE
Sci Rep; 2017 Jun; 7(1):4415. PubMed ID: 28667292
[TBL] [Abstract][Full Text] [Related]
17. Screening of TYR, OCA2, GPR143, and MC1R in patients with congenital nystagmus, macular hypoplasia, and fundus hypopigmentation indicating albinism.
Preising MN; Forster H; Gonser M; Lorenz B
Mol Vis; 2011 Apr; 17():939-48. PubMed ID: 21541274
[TBL] [Abstract][Full Text] [Related]
18. Prevalent and novel mutations of the tyrosinase gene in Korean patients with tyrosinase-deficient oculocutaneous albinism.
Park SK; Lee KH; Park KC; Lee JS; Spritz RA; Lee ST
Mol Cells; 1997 Apr; 7(2):187-91. PubMed ID: 9163730
[TBL] [Abstract][Full Text] [Related]
19. [Study of tyrosinase gene mutation in oculocutaneous albinism type 1 patients].
Zheng H; Huang ZG; Wen RQ; Li HY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2011 Aug; 27(3):329-32. PubMed ID: 22097729
[TBL] [Abstract][Full Text] [Related]
20. Detection of 53 novel DNA variations within the tyrosinase gene and accumulation of mutations in 17 patients with albinism.
Opitz S; Käsmann-Kellner B; Kaufmann M; Schwinger E; Zühlke C
Hum Mutat; 2004 Jun; 23(6):630-1. PubMed ID: 15146472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]